Dr Ene-Obong holds a PhD in Cancer Biology from University of London, a Master’s degree in human molecular genetics from Imperial College London and a Master’s degree in Business Management from Claremont Colleges, California.
Dr Abasi Ene-Obong is the Founder and Chief Executive Officer of Syndicate Bio, a platform biotech driving genomics and precision medicine initiatives across the world’s most diverse regions. Abasi is also the Founder of 54gene, an African genomics company, and served as its Chief Executive Officer for four years.
Prior to 54gene, Dr Ene-Obong worked with leading healthcare organisations, including Fortune 100 pharmaceutical companies, academic and research institutions, and governments as a management consultant with PwC. He also worked as a cancer researcher and has extensive experience operating in the US, UK, and Nigerian healthcare industries.
Dr Ene-Obong is also included in Fortune’s 40 under 40 most influential people in healthcare for the year 2020 and Endpoint News’ Top 20 under 40 in Biopharma in 2022. He is a Young Global Leader of the World Economic Forum and a Bloomberg New Economy Catalyst.
